Macrophages regulate tumor necrosis factor-α expression in adipocytes through the secretion of matrix metalloproteinase-3

International Journal of Obesity

Volumn 32, Issue 6, 2008, Pages 902-911

  Unoki, H ^a,b   Bujo, H ^a   Jiang, M ^a   Kawamura, T ^a   Murakami, K ^a   Saito, Y ^a  

^a CHIBA UNIVERSITY   (Japan)

^b INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

Author keywords

Adipocyte; Insulin resistance; Macrophage; Matrix metalloproteinase 3; Tumor necrosis factor

Indexed keywords

DEOXYGLUCOSE; GELATINASE A; GELATINASE B; GLYCEROL; ILOMASTAT; INSULIN; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE INHIBITOR; N ISOBUTYL N (4 METHOXYPHENYLSULFONYL)GLYCYLHYDROXAMIC ACID; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; GLUCOSE TRANSPORT; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID DIET; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; DIETARY FATS; DIPEPTIDES; DISEASE MODELS, ANIMAL; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MACROPHAGES; MATRIX METALLOPROTEINASE 3; MICE; MICE, INBRED C57BL; PROTEASE INHIBITORS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; MUS;

EID: 47249159833     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2008.7     Document Type: Article

References (32)

1. Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab 2004; 89: 2595-2600.
2. Garg A. Regional adiposity and insulin resistance. J Clin Endocrinol Metab 2004; 89: 4206-4210.
3. Matsuzawa Y. Adiponectin: identification, physiology and clinical relevance in metabolic and vascular disease. Atheroscler Suppl 2005; 6: 7-14.
4. Pittas AG, Joseph NA, Greenberg AS. Adipocytokines and insulin resistance. J Clin Endocrinol Metab 2004; 89: 447-452.
5. Shibasaki M, Takahashi K, Itou T, Miyazawa S, Ito M, Kobayashi J et al. Alterations of insulin sensitivity by the implantation of 3T3-L1 cells in nude mice. A role for TNF-α? Diabetologia 2002; 45: 518-526.
6. Unoki H, Bujo H, Shibasaki M, Saito Y. Increased matrix metalloproteinase-3 mRNA expression in visceral fat in mice implanted with cultured preadipocytes. Biochem Biophys Res Commun 2006; 350: 392-398.
7. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005; 115: 1111-1119.
8. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-1808.
9. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821-1830.
10. Kamei N, Tobe K, Suzuki R, Ohsugi M, Watanabe T, Kubota N et al. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 2006; 281: 26602-26614.
11. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, Kitazawa R et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006; 116: 1494-1505.
12. Suganami T, Nishida J, Ogawa Y. A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor α. Arterioscler Thromb Vasc Biol 2005; 25: 2062-2068.
13. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006; 116: 3015-3025.
14. Murakami K, Bujo H, Unoki H, Saito Y. High fat intake induces a population of adipocytes to co-express TLR2 and TNFα in mice with insulin resistance. Biochem Biophys Res Commun 2007; 354: 727-734.
15. Nguyen MT, Favelyukis S, Nguyen AK, Reichart D, Scott PA, Jenn A et al. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J Biol Chem 2007; 282: 35279-35292.
16. Murakami K, Bujo H, Unoki H, Saito Y, Murakami K, Bujo H et al. Effect of PPARα activation of macrophages on the secretion of inflammatory cytokines in cultured adipocytes. Eur J Pharmacol 2007; 561: 206-213.
17. Hirata T, Unoki H, Bujo H, Ueno K, Saito Y. Activation of diacylglycerol O-acyltransferase 1 gene results in increased tumor necrosis factor-α gene expression in 3T3-L1 adipocytes. FEBS Lett 2006; 580: 5117-5121.
18. Shibasaki M, Bujo H, Takahashi K, Murakami K, Unoki H, Saito Y. Catalytically inactive lipoprotein lipase overexpression increases insulin sensitivity in mice. Horm Metab Res 2006; 38: 491-496.
19. Ohwaki K, Bujo H, Jiang M, Yamazaki H, Schneider WJ, Saito Y. A secreted soluble form of LR11, specifically expressed in intimal smooth muscle cells, accelerates formation of lipid-laden macrophages. Arterioscler Thromb Vasc Biol 2007; 27: 1050-1056.
20. Khazen W, M'bika JP, Tomkiewicz C, Benelli C, Chany C, Achour A et al. Expression of macrophage-selective markers in human and rodent adipocytes. FEBS Lett 2005; 579: 5631-5634.
21. Cowherd RM, Lyle RE, McGehee Jr RE. Molecular regulation of adipocyte differentiation. Semin Cell Dev Biol 1999; 10: 3-10.
22. Ishikawa K, Takahashi K, Bujo H, Hashimoto N, Yagui K, Saito Y. Subcutaneous fat modulates insulin sensitivity in mice by regulating TNF-α expression in visceral fat. Horm Metab Res 2006; 38: 631-638.
23. Bouloumié A, Sengenès C, Portolan G, Galitzky J, Lafontan M. Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. Diabetes 2001; 50: 2080-2086.
24. Chavey C, Mari B, Monthouel MN, Bonnafous S, Anglard P, Van Obberghen E et al. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J Biol Chem 2003; 278: 11888-11899.
25. Maquoi E, Demeulemeester D, Voros G, Collen D, Lijnen HR. Enhanced nutritionally induced adipose tissue development in mice with stromelysin-1 gene inactivation. Thromb Haemost 2003; 89: 696-704.
26. Lijnen HR, Van HB, Frederix L, Rio MC, Collen D. Adipocyte hypertrophy in stromelysin-3 deficient mice with nutritionally induced obesity. Thromb Haemost 2002; 87: 530-535.
27. Chun TH, Hotary KB, Sabeh F, Saltiel AR, Allen ED, Weiss SJ. A pericellular collagenase directs the 3-dimensional development of white adipose tissue. Cell 2006; 125: 577-591.
28. Traurig MT, Permana PA, Nair S, Kobes S, Bogardus C, Baier LJ. Differential expression of matrix metalloproteinase 3 (MMP3) in pre-adipocytes/stromal vascular cells from nonobese nondiabetic versus obese nondiabetic Pima Indians. Diabetes 2006; 55: 3160-3165.
29. Croissandeau G, Chretien M, Mbikay M. Involvement of matrix metalloproteinases in the adipose conversion of 3T3-L1 preadipocytes. Biochem J 2002; 364: 739-746.
30. Morimoto Y, Nishikawa K, Ohashi M. KB-R7785, a novel matrix metalloproteinase inhibitor, exerts its antidiabetic effect by inhibiting tumor necrosis factor-alpha production. Life Sci 1997; 61: 795-803.
31. Kim YS, Choi DH, Block ML, Lorenzl S, Yang L, Kim YJ et al. A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation. FASEB J 2007; 21: 179-187.
32. Si-Tayeb K, Monvoisin A, Mazzocco C, Lepreux S, Decossas M, Cubel G et al. Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis. Am J Pathol 2006; 169: 1390-1401.